Keʻena Honua

Ma ʻApelila 21, 2026, ua hoʻolaha ke Kikowaena no ka Loiloi Lāʻau Lapaʻau (CDE) o ka National Medical Products Administration ua koho ʻia ʻo HS-20093 no ka injection (risvutatug rezetecan) ma ke ʻano he moho Breakthrough Therapy no ka mālama ʻana i nā maʻi me ka maʻi prostate castration-resistant holomua...E heluhelu hou aku»

I kēia mau lā aku nei, ua hoʻolaha ke Kikowaena no ka Loiloi Lāʻau Lapaʻau (CDE) o ka ʻOihana Hoʻokele Huahana Lapaʻau Lahui o Kina (NMPA) ua ʻae ʻia ʻo Encorafenib no ka loiloi mua. E hoʻohana ʻia ia me ka cetuximab a me ka regimen chemotherapy FOLFOX ma ke ʻano he lāʻau lapaʻau mua no...E heluhelu hou aku»

Ke ʻike ʻia nā huaʻōlelo "kani ʻaʻai pancreatic" ma kahi hōʻike diagnostics—ʻoi aku hoʻi i ka wā e hele pū ʻia me "25 metastases ate"—ua hoʻopilikia nui ʻia nā ʻohana he nui. ʻO kēia maʻi, i ʻike ʻia ʻo "ke aliʻi o nā maʻi ʻaʻai," i ʻike mua ʻia me nā metastases he nui, pinepine...E heluhelu hou aku»

I kēia mau lā aku nei, ua hoʻolaha ʻo Bayer ua ʻāpono ka National Medical Products Administration (NMPA) o Kina i ka lāʻau lapaʻau hou i kuhikuhi ʻia ʻo sevabertinib no ka mālama ʻana i nā poʻe maʻi makua me ka maʻi kanesa māmā non-small cell lung (NSCLC) i hiki ʻole ke hoʻopau ʻia ma kahi kūloko a i ʻole metastatic e mālama nei i ka HER2 (ERBB2) activating mutat...E heluhelu hou aku»

E nā poʻe maʻi o ka honua, Ke hakakā nei ʻoe a i ʻole kāu poʻe aloha i ka maʻi kanesa a ke ʻimi nei i nā koho lapaʻau ʻoi aku ka mālie a me ka maikaʻi, makemake mākou e hoʻolauna iā ʻoe i kahi ʻenehana oncology kipi - Ultrasound Tissue Fragmentation Therapy. Ua hoʻokō pono ʻia kēia lāʻau lapaʻau holomua...E heluhelu hou aku»

Ke hoʻolei ka maʻi kanesa i ke aka ma luna o ke ola, loaʻa i kēlā me kēia koho lapaʻau nā hopena koʻikoʻi no ka maikaʻi a me ka hanohano o kēlā ola. No nā poʻe maʻi i piha i ka ʻelemakule, he hana cardiopulmonary maikaʻi ʻole, ʻaʻole hiki ke ʻae i ke ʻoki kino a i ʻole ka anesthesia, a i ʻole e ʻimi i kahi ala mālie e hakakā ai i ka puʻupuʻu, ʻo ka ...E heluhelu hou aku»

Ma Malaki 31, 2026, ua hāʻawi ke Kikowaena no ka Loiloi Lāʻau Lapaʻau o ka ʻĀina Hoʻokele Huahana Lapaʻau Lahui o Kina i nā nūhou hoihoi: Ua hoʻokomo kūhelu ʻia ʻo GFH375, i hoʻomohala ʻia e GenFleet Therapeutics, ma ke ʻano he moho "Breakthrough Therapy" no ka mālama ʻana i nā maʻi me ka metastatic pancreatic ca...E heluhelu hou aku»

No nā poʻe maʻi kanesa ʻelemakule he nui a me ko lākou mau ʻohana, hele pinepine mai kahi hōʻailona me ka manaʻolana ʻole. ʻOi loa aku i ka wā e kū nei i ke "mōʻī o nā maʻi kanesa" - ke kanesa pancreatic - ʻo ka ʻeha nui a me ka hiki ʻole ke ʻai pinepine e hoʻonele i nā mea maʻi i ko lākou hanohano, e waiho ana i kā lākou poʻe aloha i ke kaumaha nui. I...E heluhelu hou aku»

Ma Malaki 24, 2024, ua hoʻolaha ke Kikowaena no ka Loiloi Lāʻau Lapaʻau o ka ʻĀina Hoʻokele Huahana Lapaʻau Lahui o Kina ua manaʻo ʻia ka lāʻau lapaʻau hou ʻo Teclistamab e koho ʻia ma ke ʻano he lāʻau lapaʻau holomua no ka mālama ʻana i ka monotherapy o nā poʻe maʻi makua me ka relapsed a i ʻole refractory multiple my...E heluhelu hou aku»

I kēia manawa koke nei, ua ʻae ka National Medical Products Administration (NMPA) i kahi hōʻailona hou no ka antibody-drug conjugate (ADC) Disitamab vedotin no ka mālama ʻana i nā maʻi maʻi umauma makua me ka unresectable a metastatic HER2-low expression (IHC 1+ a i ʻole IHC 2+/ISH-) a me nā metastases ate, nāna ...E heluhelu hou aku»

Ma Malaki 10, 2026, ua hāʻawi ʻia ka B7-H3-targeting antibody-drug conjugate (ADC) YL201 hou no ka injection, i hoʻomohala ʻia e MediLink Therapeutics, i ka Breakthrough Therapy Designation e ke Center for Drug Evaluation of China's National Medical Products Administration. ʻO ka hōʻailona i koho ʻia...E heluhelu hou aku»

I kēia mau lā iho nei, ua ʻae kūhelu ke Kikowaena no ka Loiloi Lāʻau Lapaʻau (CDE) o ka China National Medical Products Administration i ka inikini KSD-101, i hoʻomohala ʻia e Kousai, e komo i nā hoʻokolohua lapaʻau. ʻAʻole wale kēia ka lāʻau pale dendritic cell mua (DC vaccine) ma Kina e loaʻa i ka FDA IND app...E heluhelu hou aku»